Publication

Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation

Desai, J.
; 
Han, S. W.
; 
Forster, M. D.
; 
Kim, T. W.
; 
Casal, G. A.
; 
Shmueli, E. S.
; 
Bowyer, S. E.
; 
De Miguel, M. J.
; 
Gonzalez, A. F.
; 
Jones, R. H.
... show 10 more
Citations
Altmetric:
Abstract
Authors
Desai, J.
Han, S. W.
Forster, M. D.
Kim, T. W.
Casal, G. A.
Shmueli, E. S.
Bowyer, S. E.
De Miguel, M. J.
Gonzalez, A. F.
Jones, R. H.
Krebs, Matthew G
Miller, W. H.
Paz-Ares, L.
Lorusso, P.
Sacher, A.
Dharia, N.
Lin, M. T.
Schutzman, J. L.
Shi, Z.
Patel, M.
Affiliation
Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, VIC,Australia
Description
Date
2022
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Desai J, Han SW, Forster MD, Kim TW, Casal GA, Shmueli ES, et al. Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation. Annals of Oncology. 2022 Sep;33(7):S701-S2. PubMed PMID: WOS:000866211600356.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/625952
Embedded videos